ProCE Banner Activity

A New GOLD Standard: Updates in Managing COPD

Clinical Thought

This commentary highlights the key updates to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2024 Report, including discussion of previously undervalued aspects of COPD physiology and etiology, strategies for pharmacists to assist in COPD diagnosis, classification, and management, and practical methods to improve treatment adherence and outcomes.

Released: January 16, 2024

Share

Faculty

J. Andrew Woods

J. Andrew Woods, PharmD, BCPS

Professor and Chair
Department of Translational Science and Inpatient Practice
Wingate University School of Pharmacy
Wingate, North Carolina

Provided by

Provided by ProCE, LLC

ProCE Banner

Supporters

This program is supported in part by an independent medical educational grant from Mylan Specialty L.P., a Viatris Company and Theravance Biopharma Inc.

Mylan Specialty L.P., a Viatris Company

Theravance Biopharma Inc.

Faculty Disclosure

Primary Author

J. Andrew Woods, PharmD, BCPS

Professor and Chair
Department of Translational Science and Inpatient Practice
Wingate University School of Pharmacy
Wingate, North Carolina

J. Andrew Woods, PharmD, BCPS: consultant/advisor/speaker: Boehringer Ingelheim.